No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls

Journal of Rheumatology

Volumn 29, Issue 10, 2002, Pages 2143-2147

  Myklebust, Geirmund ^a   Wilsgaard, Tom ^a   Jacobsen, Bjarne Koster ^a   Gran, Tore Jan ^a  

^a Box 14 UNN ^*  (Norway)

Author keywords

Cancer; Malignant neoplasm; Polymyalgia rheumatica; Temporal arteritis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERITIS;

NEOPLASMS; NORWAY; POLYMYALGIA RHEUMATICA; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RANDOM ALLOCATION; TEMPORAL ARTERITIS;

EID: 0036790246     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, South Norway: A prospective study 1987-94. J Rheumatol 1997;24:1739-43.
2. Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am 1997;81:195-219.
3. Naschitz JE, Rosner I, Rozenbaum M, Elias N, Yeshurun D. Cancer-associated rheumatic disorders: Clues to occult neoplasia. Semin Arthritis Rheum 1995;24:231-41.
4. Mertens JC, Willemsen G, Van Saase JL, Bolk JH, Dijkmans BA. Polymyalgia rheumatica and temporal arteritis. A retrospective study of 111 patients. Clin Rheumatol 1995;14:650-5.
5. Sidhom OA, Basalaev M, Sigal LH. Renal cell carcinoma presenting as polymyalgia rheumatica. Resolution after nephrectomy. Arch Intern Med 1993;153:2043-5.
6. Naschitz JE, Slobodin G, Yeshurun D, Rozenbaum M, Rosner I. A polymyalgia rheumatica-like syndrome as presentation of metastatic cancer. J Clin Rheumatol 1996;2:305-8.
7. Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol 2000;27:2179-84.
8. Bahlas S, Ramos-Remus C, Davis P. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1998;25:99-104.
9. Haga HJ, Eide GE, Brun J, Johansen A, Langmark F. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1993;20:1335-9.
10. Huston KA, Hunder CG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: A 25-year epidemiological, clinical and pathological study. Ann Intern Med 1978;88:162-7.
11. Boesen P, Freiesleben F, Sorensen S. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. Arthritis Rheum 1987;30:294-9.
12. Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology 2001;40:1238-42.
13. Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996;35:1161-8.
14. Gran JT, Myklebust G. The incidence and clinical characteristics of peripheral arthritis in polymyalgia rheumatica and temporal arteritis: a prospective study of 231 cases. Rheumatology 2000;39:283-7.
15. Bird HA, Esselinckx W, Dixon ASTJ, Mowat AG, Wood PHN. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
16. Hamrin B. Polymyalgia rheumatica. Acta Med Scand 1972;533 Suppl: 1-13.
17. Chuang T-Y, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica. A 10-year epidemiologic and clinical study. Ann Intern Med 1982;97:672-80.
18. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
19. SAS/STAT user's guide. Version 6, 4th ed. Gary: SAS Institute; 1990.
20. von Knorring J, Somer T. Malignancy in association with polymyalgia rheumatica and temporal arteritis. Scand J Rheumatol 1974;3:129-35.
21. Mackenzie AH. The polymyalgia rheumatica syndrome. Geriatrics 1969;24:158-66.
22. Hunder G, Disney T, Emmerson L. Polymyalgia rheumatica. Mayo Clin Proc 1969;44:849-75.
23. Andersson R, Malmvall B-E, Bengtsson B-A. Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Acta Med Scand 1986;220:361-4.
24. Salvarani C, Macchioni PL, Tartoni PL, et al. Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiological and clinical study in Reggio, Italy. Clin Exp Rheumatol 1987;5:205-15.
25. Schaufelberger C, Bengtsson B-Å, Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol 1995;34:261-4.
26. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996;100:193-6.
27. Gonzalez-Gay MA, Garcia-Porrura C, Vázquez-Caruncho M, Dababneh A, Hajeer A, Ollier WER. The spectrum of polymyalgia rheumatica in Northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol 1999;26:1326-32.
28. Gonzalez-Gay MA, Blanco R, Abraira V, et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 1997;24:2171-6.
29. Shimamoto Y, Matsunaga C, Suga K, Fukushima N, Nomura K, Yamagushi M. A human T-cell lymphotropic virus type I carrier with temporal arteritis terminating in acute myelogenous leukemia. Scand J Rheumatol 1994;23:151-3.
30. Gabriel S, Conn D, Phyliky R, Pittelkow M, Scott R. Vasculitis in hairy cell leukemia: review of literature and consideration of possible pathogenic mechanisms. J Rheumatol 1986;13:1167-72.
31. Greer JM, Longley S, Edwards NL, Elfenbein GJ, Panush RS. Vasculitis associated with malignancy: experience with 13 patients and literature review. Medicine 1988;67:222-30.
32. Case records of the Massachusetts General Hospital. N Engl J Med 1990;322:1656-65.
33. Caldwell DS, McCallum RM. Rheumatological manifestations of cancer. Med Clin North Am 1986;70:385-417.
34. Kalra L, Delamere JP. Lymphoreticular malignancy and monoclonal gammopathy presenting as polymyalgia rheumatica. Br J Rheumatol 1987;26:458-9.
35. Kyle RA. Monoclonal gammopathy of undetermined significance (MGUS): a review. Clin Haematol 1982;2:123-50.
36. Lie JT. Simultaneous clinical manifestations of malignancy and giant cell temporal arteritis in a young woman. J Rheumatol 1995;22:367-9.
37. Montanaro M, Bizzari F. Non-Hodgkin's lymphoma and subsequent acute lymphoblastic leukaemia in a patient with polymyalgia rheumatica. Br J Rheumatol 1992;31:277-8.
38. Tabata M, Kobayashi T. Polymyalgia rheumatica and thyroid papillary carcinoma. Intern Med 1994;33:41-4.